TBI-Induced Formation of Toxic Tau and Its Biochemical Similarities to Tau in AD Brains

Abstract

The goal of the current study is to demonstrate that blast-induced traumatic brain injury (TBI) and Alzheimers disease (AD) lead to similar biochemical changes in tau that increase its toxicity and contribute to cognitive and electrophysiological impairments. Specifically we will test the hypothesis that 1) blast-induced TBI leads to the production of a toxic form of tau that contributes to cognitive and electrophysiological impairments; 2) the formation of soluble tau aggregates contributes to cognitive impairments associated with both blast-exposure and AD; 3) an increase in tau phosphorylation contributes to cognitive impairments associated with both blast-exposure and AD. During the last year we have completed experiments related to the first point of the hypothesis, and started working on the second point. Specifically, we have found that the presence of tau is necessary for a preparation from shockwave-exposed mice to reduce 1) memory including contextual fear memory and spatial memory, and 2) long-term potentiation, a type of synaptic plasticity thought to underlie learning. We have also performed a dose response curve for the toxic effect of blasted tau onto memory and LTP.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2019
Accession Number
AD1087429

Entities

People

  • Ottavio Arancio

Organizations

  • Columbia University

Tags

DTIC Thesaurus Topics

  • Alzheimer Disease
  • Blood-Brain Barrier
  • Brain
  • Brain Injuries
  • Cognitive Impairment
  • Content Addressable Memory
  • Cytoskeleton
  • Department Of Defense
  • Diseases And Disorders
  • Medical Personnel
  • Neurodegeneration
  • Neurodegenerative Diseases
  • Parkinson'S Disease
  • Phosphorylation
  • Plastic Properties
  • Toxicity
  • Veins

Fields of Study

  • Biology

Readers

  • Neuroscience
  • Traumatic Brain Injury (TBI) and Cognitive Aging in the Guam and Border Populations Affected by Alzheimer's Disease and Tau-Associated Dementias.